All posts by: Michael Zand

About Michael Zand

State earns first royalty check after investing billions in stem cell research – San Francisco Chronicle

Continue reading

2018-02-12 NEWS

San Francisco Chronicle

State earns first royalty check after investing billions in stem cell research
San Francisco Chronicle
“I think this illustrates that a state agency can actually fund research in the private community and get a return on its investment,” said John Zaia, director of City of Hope’s Alpha Stem Cell Clinic, which has been backed with roughly $8 million in
USRM Successfully Launches Stem Cell Webinar SeriesPR Newswire (press release)
Why clinics offering stem cell therapies need a caution signThe Olympian
Stem Cell Banking Market 2018-2023: Cordlife Group …News of Observer
satPRnews (press release) –DailyNewsKs
all 14 news articles »
Continue reading

2018-02-12 NEWS

Ziopharm’s Sleeping Beauty system generates CART cells in less than two days; shares up 8% premarket
Seeking Alpha
Ziopharm Oncology (NASDAQ:ZIOP) announces potential point-of-care (POC) manufacturing of CART cells using its Sleeping Beauty system. The preclinical data were presented at the Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond in
Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular …GlobeNewswire (press release)

all 7 news articles »